Multilocus Sequence Typing of Pathogenic Candida albicans Isolates Collected from a Teaching Hospital in Shanghai, China: A Molecular Epidemiology Study
Abstract:Molecular typing of Candida albicans is important for studying the population structure and epidemiology of this opportunistic yeast, such as population dynamics, nosocomial infections, multiple infections and microevolution. The genetic diversity of C. albicans has been rarely studied in China. In the present study, multilocus sequence typing (MLST) was used to characterize the genetic diversity and population structure of 62 C. albicans isolates collected from 40 patients from Huashan Hospital in Shanghai, C… Show more
“…Similarly, these clades contain the fewest strains in the global C. albicans MLST database. No isolates in Clade 13 were found in studies from Chinese regions such as Beijing 37 , Chengdu 38 , Shanghai 39 , 40 , Shenyang 41 , and Taiwan 42 – 44 . Several earlier studies found strong evidence for a geographic influence in the low representation of some clades in certain regions of the world.…”
Section: Discussionmentioning
confidence: 99%
“…In the global database, most Clade 19 isolates were from Asian subjects (China, South Korea, Iran, Kuwait). This clade was first described as clade New 1 by Wu 40 in Shanghai, China.…”
This study evaluates the prevalence, diversity, and genetic profiles of Candida albicans isolates recovered from the oral cavities of haemodialysis patients. Oral swab samples were obtained from haemodialysis patients (n = 126) and healthy control subjects (n = 233) and Candida species were characterised. There was no significant difference between the haemodialysis and control groups in the prevalence of yeast carriers (23.6% vs. 31.0%, respectively) or C. albicans carriers (19.8% vs. 21.0%, respectively). C. albicans was the most populous species in both cohorts, followed by C. parapsilosis. C. parapsilosis and C. glabrata were more prevalent in the haemodialysis group than in the control group (C. parapsilosis 5.6% vs. 0.9% and C. glabrata 3.2% vs. 0.4%, respectively; P < 0.05). C. albicans isolates were analysed by multilocus sequence typing and the results were used to construct a phylogenetic tree. Most haemodialysis isolates were placed into Clade 4 (20.0%) and Clade 19 (16.0%) and most control isolates into Clade 8 (17%) and Clade 4 (14.9%). Differences in the strain abundance in each clade were not statistically significant between the two groups. Moreover, there was no significant association between the health status or diagnosis and either the sequence types or clades.
“…Similarly, these clades contain the fewest strains in the global C. albicans MLST database. No isolates in Clade 13 were found in studies from Chinese regions such as Beijing 37 , Chengdu 38 , Shanghai 39 , 40 , Shenyang 41 , and Taiwan 42 – 44 . Several earlier studies found strong evidence for a geographic influence in the low representation of some clades in certain regions of the world.…”
Section: Discussionmentioning
confidence: 99%
“…In the global database, most Clade 19 isolates were from Asian subjects (China, South Korea, Iran, Kuwait). This clade was first described as clade New 1 by Wu 40 in Shanghai, China.…”
This study evaluates the prevalence, diversity, and genetic profiles of Candida albicans isolates recovered from the oral cavities of haemodialysis patients. Oral swab samples were obtained from haemodialysis patients (n = 126) and healthy control subjects (n = 233) and Candida species were characterised. There was no significant difference between the haemodialysis and control groups in the prevalence of yeast carriers (23.6% vs. 31.0%, respectively) or C. albicans carriers (19.8% vs. 21.0%, respectively). C. albicans was the most populous species in both cohorts, followed by C. parapsilosis. C. parapsilosis and C. glabrata were more prevalent in the haemodialysis group than in the control group (C. parapsilosis 5.6% vs. 0.9% and C. glabrata 3.2% vs. 0.4%, respectively; P < 0.05). C. albicans isolates were analysed by multilocus sequence typing and the results were used to construct a phylogenetic tree. Most haemodialysis isolates were placed into Clade 4 (20.0%) and Clade 19 (16.0%) and most control isolates into Clade 8 (17%) and Clade 4 (14.9%). Differences in the strain abundance in each clade were not statistically significant between the two groups. Moreover, there was no significant association between the health status or diagnosis and either the sequence types or clades.
“…The main source of invasive C. albicans was confirmed to originate from the endogenous mycobiota (6,130,140,141). Indeed, identity between isolates from blood and colonized anatomical sites was almost always observed, leading to the conclusion that nosocomial transmission between patients is likely a rare event (141,142), even if an outbreak is suspected (143), although some authors have reported nosocomial transmission in hospital environments (144)(145)(146)(147)(148). MLP typing has also been used to track the origin of graft site candidiasis after kidney transplantation (149).…”
Genotyping studies of medically important fungi have addressed elucidation of outbreaks, nosocomial transmissions, infection routes, and genotype-phenotype correlations, of which secondary resistance has been most intensively investigated. Two methods have emerged because of their high discriminatory power and reproducibility: multilocus sequence typing (MLST) and microsatellite length polymorphism (MLP) using short tandem repeat (STR) markers. MLST relies on single-nucleotide polymorphisms within the coding regions of housekeeping genes. STR polymorphisms are based on the number of repeats of short DNA fragments, mostly outside coding regions, and thus are expected to be more polymorphic and more rapidly evolving than MLST markers. There is no consensus on a universal typing system. Either one or both of these approaches are now available for spp., spp., spp., spp., ,, and endemic mycoses. The choice of the method and the number of loci to be tested depend on the clinical question being addressed. Next-generation sequencing is becoming the most appropriate method for fungi with no MLP or MLST typing available. Whatever the molecular tool used, collection of clinical data (e.g., time of hospitalization and sharing of similar rooms) is mandatory for investigating outbreaks and nosocomial transmission.
“…12 Some STs were the same among isolates from different patients, supporting nosocomial transmission among patients. 10,16 The differences in the number of STs identified in this study compared to other studies may have been the result of different geographic regions. 26,27 Moreover, the differences in the STs identified among the isolates from Shenzhen People's Hospital and other Chinese hospitals 10,15 suggest that the genetic complexity is different among the communities of C. albicans in different hospitals.…”
Section: Albicans Strainsmentioning
confidence: 56%
“…9 Molecular biology typing methods, such as MLST and MLVA, are very useful for epidemiological investigation and nosocomial infection surveillance of C. albicans in hospital wards. 10 Indeed, MLST is performed easily and can be used to group C. albicans isolates in a similar way to Ca3 Southern hybridization. 11 It has been used to study the geographic distribution, 12e14 population structure, 13 infection regions, 15 prevalence, 15 diversity, 16 microevolution, 10,16 genetic basis of pathogenicity, 17 and drug resistance 13,18 of C. albicans.…”
Although there was no core ST detected to specify pathogenicity or colonization of C. albicans, the genotypes of the colonization strains were different from those of the pathogenic strains. Most of the colonization and pathogenic strains were highly homologous within their classifications while some pathogenic strains had genomes highly homologous with those of colonization strains and clustered in heterogeneous groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.